Laboratory of Neurocognitive Development
Pittsburgh, Pennsylvania, 15213, United States
NCT Number: NCT07569718
The study will use a PET-based measure of brain cell (neuron) connections (synapses) in young adults who have also obtained an MRI, to assess how the loss of brain cell connections (synaptic pruning) is captured by MRI-based measures. This will inform youth MRI studies to understand neurotypical brain development that can help identify abnormal trajectories as in mental illness.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15213, United States
The loss of brain cell (neuron) connections (synapses) through human development, known as synaptic pruning, has been characterized in postmortem studies but how this proceeds in live humans as they age into adulthood is not well understood. This study will use the PET tracer [11C]UCB-J which provides a direct measure of synaptic density, in conjunction with previously acquired ultra-high field MRI, in a group of young adults in order to understand how standard MRI-based measures reflect changes in the density of synapses. PET [11C]UCB-J is known to measure the density of synaptic connections by measuring a protein (SV2A) present in synapses. A comparison of results from the current study with MRI-based measures of byproducts of synaptic membrane breakdown from childhood to early adulthood will allow assessment of how non-invasive MRI reflects synaptic pruning through development, facilitating studies of how the brain changes through adolescence and into adulthood, which is needed to identify patterns of development associated with the emergence of mental illness.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
(these exclusion criteria are outlined in the Parent Project)
[11C]UCB-J (~ 15 mCi and ≤ 6μg) will be injected as a slow intravenous bolus. Following an intravenous bolus injection of [11C]UCB-J, the participants will be positioned in the scanner for a low dose CT scan (for attenuation correction) fifty-five minutes after the [11C]UCB-J injection, and emission data will be collected.
Time frame: The PET-CT scan will be within approximately 30 days of the parent study MRI.
o Cross-sectional age-related (18-26 years of age) changes in synaptic density via SUVR quantified within the dorsolateral prefrontal cortex.
Time frame: The PET-CT scan will be within approximately 30 days of the parent study MRI.
o Synaptic density, based on SUVR modeling of [11C]UCB-J acquisitions, will be compared to ultra-high field (7 Tesla) [31P]MRSI measurement of membrane phospholipid levels obtained from the same participants.
Beatriz Luna
Other
Acronym: SPA PET
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07699120
Chemically-Induced Disorders, Healthy Adult Participants
Toronto, Ontario, Canada
View Trial DetailsNCT07644676
Healthy Adult Participants, Stomatognathic Diseases
Hörby, Skåne County, Sweden
View Trial DetailsNCT07536685
Healthy Adult Participants
Kütahya, Turkey (Türkiye)
View Trial DetailsNCT07514741
Healthy Adult Participants
West Hollywood, California, United States
View Trial Details